Key Record Dates
ClinicalTrials.gov Identifier: | NCT05997277 |
---|---|
Brief Title: | Evaluating the Safety and Efficacy of Deucravacitinib Compared to Placebo Hidradenitis Suppurativa (HS). |
First Submitted : | August 10, 2023 |
First Submitted that Met QC Criteria : | August 10, 2023 |
First Posted : | August 18, 2023 |
Last Update Submitted that Met QC Criteria : | February 3, 2024 |
Last Update Posted : | February 6, 2024 |